Article Figures & Data
Tables
TREATMENT PLAN GAD CLINICAL SCENARIO (N = 160), N (%) MDE CLINICAL SCENARIO (N = 171), N (%) Immediate* • Pharmacotherapy alone 42 (26.3) 22 (12.9) • Counseling† alone 6 (3.8) 12 (7.0) • Pharmacotherapy and counseling 40 (25.0) 27 (15.8) • Pharmacotherapy or counseling plus other‡ 14 (8.8) 18 (10.5) • Other alone 3 (1.9) 16 (9.4) • Total immediate 105 (65.6) 95 (55.6) Delayed • Pharmacotherapy alone 12 (7.5) 7 (4.1) • Counseling† alone 3 (1.9) 1 (0.6) • Pharmacotherapy and counseling 3 (1.9) 6 (3.5) • Pharmacotherapy or counseling plus other‡ 2 (1.3) 3 (1.8) • Other alone 0 1 (0.5) • Await results before deciding 25 (15.6) 41 (24.0) • Total delayed 45 (28.1) 59 (34.5) No treatment 3 (1.9) 2 (7.0) No response 7 (4.4) 5 (2.9) -
GAD—generalized anxiety disorder, MDE—major depressive episode.
-
↵* Statements considered indicative of “immediate” treatment included those that did not refer to delaying treatment, delaying a decision regarding treatment, or awaiting laboratory results.
-
↵† Included counseling by a family physician and referral for counseling.
-
↵‡ Treatment or action other than pharmacotherapy and counseling, such as breathing techniques, reassurance, education, and recommendations of more sun, dietary changes, exercise, diary writing, books to read, meditation, sleep, rest, stress reduction, and sick leave.
-
- Table 2
Physicians’ suggested length of time to the first follow-up visit for GAD and MDE clinical-scenario patients
TIME ELAPSED UNTIL FIRST FOLLOW-UP GAD CLINICAL SCENARIO (N = 160), N (%) MDE CLINICAL SCENARIO (N = 171), N (%) 1 wk or sooner 55 (34.4) 59 (34.5) 1–2 wk 72 (45.0) 82 (48.0) 3–4 wk 8 (5.0) 7 (4.1) More than 4 wk 10 (6.3) 11 (6.4) No response 15 (9.4) 12 (7.0) -
GAD—generalized anxiety disorder, MDE—major depressive episode.
-
- Table 3
Physicians’ perceived barriers to providing optimal care to GAD and MDE clinical-scenario patients
BARRIERS TO CARE GAD CLINICAL SCENARIO (N = 160), N (%) MDE CLINICAL SCENARIO (N = 171), N (%) Any barrier mentioned* 107 (66.9) 111 (64.9) Physician-related barriers • Too busy 28 (17.5) 27 (15.8) • Requires specialist referral or consultation 12 (7.5) 11 (6.4) • Does not provide counseling 8 (5.0) 6 (3.5) • Needs more information 4 (2.5) 7 (4.1) • Cannot immediately diagnose 1 (0.6) 9 (5.3) • Needs to rule out organic cause 2 (1.3) 5 (2.9) • Diagnostic uncertainty 3 (1.9) 3 (1.8) • Lacks knowledge, skills, or experience 10 (6.3) 1 (0.6) • Other 7 (4.4) 14 (8.2) • Any physician barrier 63 (39.4) 68 (39.8) Patient-related barriers • Noncompliant 16 (10.0) 21 (12.3) • Resists diagnosis 6 (3.8) 9 (5.3) • Cannot afford treatment 5 (3.1) 7 (4.1) • Complex condition 6 (3.8) 2 (1.2) • Condition persists 3 (1.9) 6 (3.5) • Drug addiction 7 (4.4) 1 (0.6) • Suicidal 4 (2.5) 3 (1.8) • History incomplete 2 (1.3) 3 (1.8) • Wants physical diagnosis 2 (1.3) 1 (0.6) • Condition is comorbid 2 (1.3) 1 (0.6) • Other 1 (0.6) 3 (1.8) • Any patient barrier 40 (25.0) 36 (21.1) System access–related barriers • Counseling 14 (8.8) 16 (9.4) • Psychiatrist 7 (4.4) 8 (4.7) • Laboratory results 3 (1.9) 8 (4.7) • Specialist 1 (0.6) 4 (2.3) • CBT provider 3 (1.9) 2 (1.2) • Other 6 (3.8) 7 (4.1) • Any system barrier 30 (18.8) 36 (21.1) No response 53 (33.1) 60 (35.1) -
CBT—cognitive behavioural therapy, GAD—generalized anxiety disorder, MDE—major depressive episode.
-
↵* Respondents might have noted more than 1 barrier; therefore, categories of “any barrier” do not total 100%.
-






